Correlation Between Caribou Biosciences and MAIA Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and MAIA Biotechnology, you can compare the effects of market volatilities on Caribou Biosciences and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and MAIA Biotechnology.

Diversification Opportunities for Caribou Biosciences and MAIA Biotechnology

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Caribou and MAIA is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and MAIA Biotechnology go up and down completely randomly.

Pair Corralation between Caribou Biosciences and MAIA Biotechnology

Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.04 times more return on investment than MAIA Biotechnology. However, Caribou Biosciences is 1.04 times more volatile than MAIA Biotechnology. It trades about -0.03 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.06 per unit of risk. If you would invest  299.00  in Caribou Biosciences on September 24, 2024 and sell it today you would lose (119.00) from holding Caribou Biosciences or give up 39.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Caribou Biosciences  vs.  MAIA Biotechnology

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Caribou Biosciences and MAIA Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and MAIA Biotechnology

The main advantage of trading using opposite Caribou Biosciences and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.
The idea behind Caribou Biosciences and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world